Ziad A Ali MD DPhil
Clinical
Dr. Ali is a board-certified cardiologist specializing in interventional and structural cardiology at St Francis Hospital and Heart Center in Roslyn, New York.
Dr. Ali is an internationally renowned expert in complex high-risk indicated percutaneous coronary interventions (CHIP) including the treatment of chronic total occlusions (CTO) where the arteries in the heart become completely blocked.
Dr. Ali specializes in the management of cardiovascular disease in patients with pre-existing kidney disease.
Research
Dr Ali’s research interests focus on the use of advanced imaging and physiology technologies to optimize stent implantation, with a particular interest in how these modalities protect patients from kidney injury by sparing or eliminating the need for contrast.
Dr Ali has held continuous National Institute of Health (NIH) research support for over a decade.· To date, Dr Ali has published more than 200 original research and review articles in peer-reviewed journals.
Dr Ali holds investigator awards from the European Vascular Society, British Cardiovascular Society, British Atherosclerosis Society, American College of Cardiology, American Heart Association, Cardiovascular Research Foundation and European Association of Percutaneous Coronary Intervention.
Dr Ali serves on the Editorial Board for three major cardiovascular journals and peer reviews regularly for over 20 journals. Dr Ali also write’s curriculum for the American College of Cardiology.
Dr Ali has been and is the Global Principal Investigator of multiple multicenter randomized trials.
Innovation
Dr Ali developed the Resting Full-Cycle Ratio (RFR) (Abbott, Santa Clara, CA), a technology which allows interventional cardiologists to determine whether heart artery blockages warrant treatment with stents or are better served with conservative management.
Dr Ali was instrumental in the development of intravascular lithotripsy (Shockwave Medical, Santa Clara, CA), a technology which uses the age-old technique of breaking kidney stones with electrical energy, to allow treatment of calcium build up in the heart arteries.
Dr Ali developed pioneering techniques to perform coronary angiography with less than a tablespoon of contrast (≈10mL) (ultra-low contrast angiography), protecting patients with advanced kidney disease from contrast associated acute kidney injury and the potential need for dialysis.
By using his expertise in intravascular imaging and physiology, Dr Ali established the techniques to perform vascular interventions, including arterial stent placement, completely free of contrast administration.
Academic
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology and Director of the Cardio-renal program at St Francis Hospital and Heart Center in New York.
He is Director of the Angiographic Core Laboratory at the Cardiovascular Research Foundation
Offering In-Office or Telehealth Visits
We know there is no such thing as a one-size-fits-all treatment plan, so we never force a one-size-fits-all approach to how to see your doctor.
Selected Services
Exercise Treadmill Test
Nuclear Stress Test (SPECT/PET)
Cardiac CT (Coronary [Heartflow]/structural)
Cardiac MRI (Stress/structural)
Cardiac Catheterization
o Right heart catheterization for cardiac pressures
o Left heart catheterization for cardiac pressures
o Coronary angiography
o Ultra-low contrast coronary angiography
Percutaneous Coronary Intervention
o Balloon angioplasty
o Stent Placement
Complex Coronary Intervention
o Coronary Atherectomy and Intravascular Lithotripsy for Severe Coronary Calcium
o Bifurcation stenting for branch artery disease
o Chronic Total Occlusion stenting for completely blocked arteries
o Zero-contrast (dyeless) coronary artery stenting
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter Mitral Edge-Edge Repair
o MitraClip (Abbott, Santa Clara, CA)
Left Atrial Appendage Closure
o Watchman (Boston Scientific, Minneapolis, MN )